Emicizumab-mediated hemostatic function assessed by thrombin generation assay in an in vitro model of factor VIII-depleted thrombophilia plasma.

Autor: Yada K; Department of Pediatrics, Nara Medical University, 840 Shijo-Cho, Kashihara, Nara, 634-8522, Japan. k-yada@naramed-u.ac.jp.; Division of Hemophilia, National Hospital Organization Osaka National Hospital, Osaka, Japan. k-yada@naramed-u.ac.jp., Ogiwara K; Department of Pediatrics, Nara Medical University, 840 Shijo-Cho, Kashihara, Nara, 634-8522, Japan., Shimonishi N; Department of Pediatrics, Nara Medical University, 840 Shijo-Cho, Kashihara, Nara, 634-8522, Japan.; The Course of Thrombosis and Hemostasis Molecular Pathology, Nara Medical University, Kashihara, Japan., Nakajima Y; Department of Pediatrics, Nara Medical University, 840 Shijo-Cho, Kashihara, Nara, 634-8522, Japan.; Advanced Medical Science of Thrombosis and Hemostasis, Nara Medical University, Kashihara, Japan., Soeda T; Research Division, Chugai Pharmaceutical Co., Ltd, Kamakura, Japan., Kitazawa T; Research Division, Chugai Pharmaceutical Co., Ltd, Kamakura, Japan., Nogami K; Department of Pediatrics, Nara Medical University, 840 Shijo-Cho, Kashihara, Nara, 634-8522, Japan.

Publikováno v: International journal of hematology [Int J Hematol] 2024 Feb; Vol. 119 (2), pp. 109-118. Date of Electronic Publication: 2023 Dec 19.

The protective effect of anti-VEGF-A/Ang-2 bispecific antibody on retinal vein occlusion model mice.

Autor: Kuriyama A; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan., Nakamura S; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan., Inokuchi Y; Product Research Dept., Chugai Pharmaceutical Co., Ltd. Kanagawa, Japan., Abe H; Product Research Dept., Chugai Pharmaceutical Co., Ltd. Kanagawa, Japan., Yasuda H; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan., Hidaka Y; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan., Nagaoka K; Product Research Dept., Chugai Pharmaceutical Co., Ltd. Kanagawa, Japan., Soeda T; Product Research Dept., Chugai Pharmaceutical Co., Ltd. Kanagawa, Japan., Shimazawa M; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan., Hara H; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan. Electronic address: hidehara@gifu-pu.ac.jp.

Publikováno v: European journal of pharmacology [Eur J Pharmacol] 2024 Aug 05; Vol. 976, pp. 176691. Date of Electronic Publication: 2024 May 29.

Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti‐idiotype monoclonal antibodies

Autor: Nogami, K. ^*, Soeda, T., Matsumoto, T., Kawabe, Y., Kitazawa, T., Shima, M.

Publikováno v: In Journal of Thrombosis and Haemostasis July 2018 16(7):1383-1390

Author Correction: Optical coherence tomography in coronary atherosclerosis assessment and intervention.

Autor: Araki M; Massachusetts General Hospital, Boston, MA, USA., Park SJ; Asan Medical Center, Seoul, South Korea., Dauerman HL; University of Vermont, Burlington, VT, USA., Uemura S; Kawasaki Medical School, Okayama, Japan., Kim JS; Yonsei University College of Medicine, Seoul, South Korea., Di Mario C; Careggi University Hospital, Florence, Italy., Johnson TW; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Guagliumi G; Ospedale Papa Giovanni XXIII, Bergamo, Italy., Kastrati A; Technische Universität München and Munich Heart Alliance, Munich, Germany., Joner M; German Heart Center, Munich, Germany., Holm NR; Aarhus University Hospital, Skejby, Denmark., Alfonso F; Hospital Universitario La Princesa, Madrid, Spain., Wijns W; National University of Ireland Galway and Saolta University Healthcare Group, Galway, Ireland., Adriaenssens T; University Hospitals Leuven, Leuven, Belgium., Nef H; University of Giessen, Giessen, Germany., Rioufol G; Hospices Civils de Lyon and Claude Bernard University, Lyon, France., Amabile N; Institut Mutualiste Montsouris, Paris, France., Souteyrand G; University Hospital of Clermont Ferrand, Clermont-Ferrand, France., Meneveau N; University Hospital Jean Minjoz, Besançon, France., Gerbaud E; University Hospital of Bordeaux, Pessac, France., Opolski MP; National Institute of Cardiology, Warsaw, Poland., Gonzalo N; Hospital Clinico San Carlos, IdISSC, Universidad Complutense, Madrid, Spain., Tearney GJ; Massachusetts General Hospital, Boston, MA, USA., Bouma B; Massachusetts General Hospital, Boston, MA, USA., Aguirre AD; Massachusetts General Hospital, Boston, MA, USA., Mintz GS; Cardiovascular Research Foundation, New York, NY, USA., Stone GW; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Bourantas CV; Barts Health NHS Trust, University College London and Queen Mary University London, London, UK., Räber L; Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Gili S; Centro Cardiologico Monzino, IRCCS, Milan, Italy., Mizuno K; Mitsukoshi Health and Welfare Foundation, Tokyo, Japan., Kimura S; Yokohama Minami Kyosai Hospital, Kanagawa, Japan., Shinke T; Showa University Hospital, Tokyo, Japan., Hong MK; Yonsei University College of Medicine, Seoul, South Korea., Jang Y; Yonsei University College of Medicine, Seoul, South Korea., Cho JM; Kyung Hee University, Seoul, South Korea., Yan BP; Chinese University of Hong Kong, Hong Kong, Hong Kong., Porto I; University of Genoa, Genoa, Italy, San Martino Hospital, IRCCS for Oncology and Neurosciences, Genoa, Italy., Niccoli G; University of Parma, Parma University Hospital, Parma, Italy., Montone RA; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Thondapu V; Massachusetts General Hospital, Boston, MA, USA., Papafaklis MI; University Hospital of Ioannina, Ioannina, Greece., Michalis LK; University Hospital of Ioannina, Ioannina, Greece., Reynolds H; New York University Grossman School of Medicine, New York, NY, USA., Saw J; Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Libby P; Brigham and Women's Hospital, Boston, MA, USA., Weisz G; New York Presbyterian Hospital, Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY, USA., Iannaccone M; Ospedale San Giovanni Bosco, Turin, Italy., Gori T; Universitäts medizin Mainz and DZHK Rhein-Main, Mainz, Germany., Toutouzas K; National and Kapodistrian University of Athens, Athens, Greece., Yonetsu T; Tokyo Medical and Dental University, Tokyo, Japan., Minami Y; Kitasato University School of Medicine, Kanagawa, Japan., Takano M; Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan., Raffel OC; The Prince Charles Hospital, Chermside, Queensland, Australia., Kurihara O; Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan., Soeda T; Nara Medical University, Nara, Japan., Sugiyama T; Tsuchiura Kyodo General Hospital, Ibaraki, Japan., Kim HO; Kyung Hee University, Seoul, South Korea., Lee T; Japanese Red Cross Musashino Hospital, Tokyo, Japan., Higuma T; Kawasaki Municipal Tama Hospital, St. Marianna University School of Medicine, Kanagawa, Japan., Nakajima A; Massachusetts General Hospital, Boston, MA, USA., Yamamoto E; Kyoto University Graduate School of Medicine, Kyoto, Japan., Bryniarski KL; Jagiellonian University Medical College, Institute of Cardiology, Department of Interventional Cardiology, John Paul II Hospital, Krakow, Poland., Di Vito L; Mazzoni Hospital, Ascoli Piceno, Italy., Vergallo R; Catholic University of the Sacred Heart, Rome, Italy., Fracassi F; Catholic University of the Sacred Heart, Rome, Italy., Russo M; Catholic University of the Sacred Heart, Rome, Italy., Seegers LM; Massachusetts General Hospital, Boston, MA, USA., McNulty I; Massachusetts General Hospital, Boston, MA, USA., Park S; Korea Advanced Institute of Science and Technology, Daejeon, South Korea., Feldman M; University of Texas Health, San Antonio, TX, USA., Escaned J; Hospital Clínico San Carlos, Madrid, Spain., Prati F; UniCamillus - Saint Camillus International University of Health Sciences, Rome, Italy., Arbustini E; IRCCS Foundation University Hospital Policlinico San Matteo, Pavia, Italy., Pinto FJ; Santa Maria University Hospital, CHULN Center of Cardiology of the University of Lisbon, Lisbon School of Medicine, Lisbon Academic Medical Center, Lisbon, Portugal., Waksman R; MedStar Washington Hospital Center, Washington, DC, USA., Garcia-Garcia HM; MedStar Washington Hospital Center, Washington, DC, USA., Maehara A; Cardiovascular Research Foundation, New York, NY, USA., Ali Z; Cardiovascular Research Foundation, New York, NY, USA., Finn AV; CV Path Institute, Gaithersburg, MD, USA., Virmani R; CV Path Institute, Gaithersburg, MD, USA., Kini AS; Mount Sinai Hospital, New York, NY, USA., Daemen J; Erasmus University Medical Centre, Rotterdam, Netherlands., Kume T; Kawasaki Medical School, Okayama, Japan., Hibi K; Yokohama City University Medical Center, Kanagawa, Japan., Tanaka A; Wakayama Medical University, Wakayama, Japan., Akasaka T; Wakayama Medical University, Wakayama, Japan., Kubo T; Wakayama Medical University, Wakayama, Japan., Yasuda S; Tohoku University Graduate School of Medicine, Sendai, Japan., Croce K; Brigham and Women's Hospital, Boston, MA, USA., Granada JF; Cardiovascular Research Foundation, New York, NY, USA., Lerman A; Mayo Clinic, Rochester, MN, USA., Prasad A; Mayo Clinic, Rochester, MN, USA., Regar E; University Hospital Zürich, Zürich, Switzerland., Saito Y; Gifu University Graduate School of Medicine, Gifu, Japan., Sankardas MA; Madras Medical Mission, Chennai, India., Subban V; Madras Medical Mission, Chennai, India., Weissman NJ; MedStar Health Research Institute, Washington, DC, USA., Chen Y; Sixth Medical Center, Chinese PLA General Hospital, Beijing, China., Yu B; The Second Affiliated Hospital of Harbin Medical University, Harbin, China., Nicholls SJ; Monash University, Melbourne, Victoria, Australia., Barlis P; University of Melbourne, Melbourne, Victoria, Australia., West NEJ; Royal Papworth Hospital, Cambridge, UK., Arbab-Zadeh A; Johns Hopkins University, Baltimore, MD, USA., Ye JC; Korea Advanced Institute of Science and Technology, Daejeon, South Korea., Dijkstra J; Leiden University Medical Centre, Leiden, Netherlands., Lee H; Massachusetts General Hospital, Boston, MA, USA., Narula J; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Crea F; Catholic University of the Sacred Heart, Rome, Italy., Nakamura S; New Tokyo Hospital, Chiba, Japan., Kakuta T; Tsuchiura Kyodo General Hospital, Ibaraki, Japan., Fujimoto J; Massachusetts Institute of Technology, Cambridge, MA, USA., Fuster V; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Jang IK; Massachusetts General Hospital, Boston, MA, USA. ijang@mgh.harvard.edu.; Kyung Hee University, Seoul, South Korea. ijang@mgh.harvard.edu.

Publikováno v: Nature reviews. Cardiology [Nat Rev Cardiol] 2024 May; Vol. 21 (5), pp. 348.

The in vitro effect of anticoagulant agents on coagulation and fibrinolysis in the presence of emicizumab in the plasmas from patients with haemophilia A.

Autor: Onishi T; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan., Harada S; Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japan., Shimo H; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan., Tashiro Y; Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japan., Soeda T; Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japan., Nogami K; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.

Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2023 Nov; Vol. 29 (6), pp. 1529-1538. Date of Electronic Publication: 2023 Sep 27.